Asian Paints Ltd Analyst Rating
based on 36 analysts
25.00%
Buy
30.56%
Hold
44.44%
Sell
Based on 36 analysts offering long term price targets for Asian Paints Ltd. An average target of ₹2661.08
Source: S&P Global Market Intelligence
Asian Paints Ltd Share analysis
Asian Paints Ltd price forecast by 36 analysts
Upside of16.11%
High
₹3750
Target
₹2661.08
Low
₹2080
Asian Paints Ltd target price ₹2661.08, a slight upside of 16.11% compared to current price of ₹2282.35. According to 36 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Asian Paints Ltd revenue growth forecast
Expected growth rate Q1, FY2026:9.98%
Forecast
Actual
Including amortisation and stock based compensations
Asian Paints Ltd EPS growth forecast
EPS estimate Q1, FY2026:
Forecast
Actual
Source: S&P Global Market Intelligence
Asian Paints Ltd Performance
Day's Low
Day's High
₹2,276Day's Price Range₹2,31852 Week's Low
52 Week's High
₹2,27652-Week Price Range₹3,422.95
| Returns % | |
| 1 Month Return | -5.61 % |
| 3 Month Return | -30.07 % |
| 1 Year Return | -30.61 % |
| Market Stats | |
| Previous Close | ₹2,291.85 |
| Open | ₹2,297.00 |
| Volume | 17.20L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,24,975.05Cr |
Asian Paints Ltd Key Statistics
| P/E Ratio | 48.09 |
| PEG Ratio | -9.36 |
| Market Cap | ₹2,24,975.05 Cr |
| P/B Ratio | 14.82 |
| EPS | 57.94 |
| Dividend Yield | 1.17 |
| Sector | Paints/Varnish |
| ROE | 31.29 |
Asian Paints Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹2,24,975.05 Cr | 5.36% | 0.54 | ₹5,557 Cr | ₹35,494 Cr | |
| HOLD | ₹1,55,516.21 Cr | 23.41% | 0.52 | ₹1,747 Cr | ₹12,382 Cr | |
| ₹52,794.66 Cr | 0.54% | 0.56 | ₹1,169 Cr | ₹11,198 Cr | ||
| HOLD | ₹21,091.31 Cr | -5.33% | 0.51 | ₹1,175 Cr | ₹7,801 Cr | |
| BUY | ₹6,834.63 Cr | -10.7% | 0.51 | ₹148 Cr | ₹1,306 Cr |
Asian Paints Ltd Mutual Fund Holdings
About Asian Paints Ltd
Asian Paints Ltd. provides a wide range of products and services in the painting industry. Its main lines of business include decorative paints, industrial coatings, automotive coatings, wood finishes, and waterproofing solutions. The company's top products include Royale Luxury Emulsion, Royale Play, and Apcolite Premium Emulsion. Asian Paints Ltd. also has a wide range of popular brands, such as Royale, Apex, Apcolite, and Weathercoat.
Share Price: ₹2282.35 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹2,24,975.05Cr as of today
Revenue: ₹8,003.02Cr as on September 2024 (Q3 24)
Net Profit: ₹693.66Cr as on September 2024 (Q3 24)
Listing date: 03 Nov, 1994
Chairperson Name: Deepak Satwalekar
| Organisation | Asian Paints Ltd |
| Headquarters | |
| Industry | Paints/Varnish |
| E-voting on shares | Click here to vote |
Key events for Asian Paints Ltd
Asian Paints Shares Plummet Amid Executive Resignations - 19 Dec, 2024
Asian Paints Ltd experienced significant stock declines following the resignation of three senior executives, hitting a 52-week low. The company faces leadership instability, impacting investor confidence.Asian Paints Faces Executive Resignations and Growth Concerns - 18 Dec, 2024
Asian Paints announced the resignation of two senior executives and is expected to see slower growth due to urban consumption challenges. The stock has dropped 31% from its peak, facing its worst calendar year returns, with many analysts recommending a sell.Asian Paints Expands Studio, Faces Sales Decline - 13 Dec, 2024
Asian Paints opened a new Beautiful Homes Studio in Surat, enhancing its luxury decor offerings. However, the company reported a 5.3% YoY decline in Q2FY25 net sales due to weak demand and competitive pressures.LIC Boosts Stake in Asian Paints Amid Challenges - 11 Dec, 2024
LIC has increased its stake in Asian Paints to 7.01%, which positively impacted the stock price despite a significant decline in Q2 FY25 profits due to weak demand and economic factors.LIC Boosts Stake in Asian Paints Amid Challenges - 10 Dec, 2024
Life Insurance Corporation of India raised its stake in Asian Paints to 7.01% through open market purchases, amid a challenging market environment and a 30% decline in share price this year.Asian Paints Reports Declining Profits Amid Challenges - 05 Dec, 2024
Asian Paints Ltd is experiencing significant challenges, reporting a 42.4% decline in net profit for Q2 FY25 due to weak demand and competition. Investor confidence is shaken as the company navigates a tough market landscape.Asian Paints Faces Decline Amidst Tough Competition - 04 Dec, 2024
Asian Paints reported a challenging Q2 FY25, with net sales down 5.3% and profit after tax dropping 42.4% due to intensified competition and adverse weather conditions. The company is adapting by increasing dealer margins and launching new products, but demand remains subdued.Asian Paints Faces Significant Underperformance Concerns - 29 Nov, 2024
Asian Paints has underperformed the market, down 30% from its 52-week highs and 20% over the last three years. Profitability issues and intense competition raise concerns about its future prospects, with potential EPS dropping to Rs 50. The stock's fair value estimates range from Rs 2,500 to Rs 3,050, indicating uncertainty in its risk-reward equation.Asian Paints Reports Profit Decline Amid Competition - 28 Nov, 2024
Asian Paints Ltd reported a significant 42.4% decline in Q2FY25 net profit to Rs 694.64 crore, alongside a 5.3% drop in revenue. The company is facing challenges from weak demand and increased competition from JSW and Birla Group.Asian Paints Expands Retail Network Amid Rising Costs - 25 Nov, 2024
Asian Paints is expanding its retail network by adding 5,000 to 8,000 new retailers annually. However, employee expenses surged by 13.5% to Rs 676.50 crore in Q2.Asian Paints Shows Strong Fundamentals Amid Market Pressures - 22 Nov, 2024
Asian Paints reports a sales CAGR of 10.44% and an impressive EPS CAGR of 34.23%, indicating strong operational efficiencies. Despite a -28% stock price return, the fundamentals remain robust, suggesting potential undervaluation. The stock trades at a P/E of 49, below its historical median of 76.4, indicating possible investment opportunities.Asian Paints Strengthens Market Position with New Initiatives - 21 Nov, 2024
Asian Paints, holding a 45-50% share in India's decorative paints market, is enhancing consumer engagement through corporate branding, loyalty programs for contractors, and improved dealer margins to counter competition.
Insights on Asian Paints Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 3.80% to 4.86% in Sep 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 15.27% to 15.28% in Sep 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 52.63% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Solar Industries India Ltd has given 334.5% return, outperforming this stock by 362.1%
- NO EFFECT
Against Peers
In the last 1 year, Solar Industries India Ltd has given 52.7% return, outperforming this stock by 82.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 4 quarters, 1.44K Cr → 694.64 Cr (in ₹), with an average decrease of 20.2% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 19.69% to 18.88% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, ASIANPAINT stock has moved down by -28.8%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 9.16K Cr → 8.23K Cr (in ₹), with an average decrease of 10.2% per quarter
News
Factors Behind the Rise in Dr Reddys Share Price
Recently, Dr Reddys share price has gained significant attention. Over the last five days, its share price surged 7.6%. Dr Reddys Laboratories is gaining attention due to its strategic focus on long-term growth and emerging markets. Despite underperforming against the Nifty Pharma Index over the last 1-5 years, international brokerage firms have upgraded their price targets for the company. This upgrade indicates confidence in Dr Reddys ability to overcome near-term hurdles and leverage future growth opportunities. The stocks recent challenges stem from heavy dependence on gRevlimid, whose sales are expected to decline by FY26, and increased overheads linked to rising investments in R&D, biosimilar trials, and manufacturing upgrades. These investments have led to temporary pressure on profit margins. For instance, earnings before interest, tax, depreciation, and amortisation (EBITDA) margins are forecasted to remain slightly under the pressure through FY27. However, analysts project accelerated earnings growth starting FY28 as new revenue streams such as GLP-1 APIs, biosimilars, and injectables mature. Dr Reddys is expanding its manufacturing infrastructure, focusing on high-demand areas like peptide APIs and injectables. It is also poised to capitalise on low-competition injectable launches in the US and growth in emerging markets, including India and Canada. The Canadian semaglutide market, estimated at US $ 1-1.5 billion (bn), offers a significant opportunity post the 2026 patent expiry. The companys ability to transition from near-term challenges to medium and long-term growth is driving investor optimism. Strategic investments, new market opportunities, and innovative initiatives position Dr Reddys for sustained growth, contributing to its recent share price surge. In the past five days, Dr Reddys share price is up 6.9%. In the last month, it has rallied 12.5%. In 2024, so far it has rallied 15.5%. Additionally, it surged 20.6% in the last year. The stock touched its 52-week high of Rs 1,420.2 on 21 August 2024 and a 52-week low of Rs 1,094.9 on 21 December 2023.20 Dec, 2024 06:13 PMStock Market Crash: Nifty Stocks with Positive Returns This Week
Dr Reddys Laboratories was recently upgraded by Nomura, with a price target of ₹1,500 per share. Nomura believes concerns about the high contribution of Revlimid have already been priced in. In the first half of the 2024-25 fiscal year, a large part of the companys growth was driven by initiatives, including clinical trials for biosimilars. The brokerage highlighted that Dr. Reddys Laboratories has significantly increased investments in manufacturing infrastructure, with its capex more than doubling in FY25. Moreover, the potential upside from GLP-1 and biosimilars has not been fully accounted for in FY27 estimates.20 Dec, 2024 04:48 PMIndian Equity Indices End Week Lower: Key Gainers and Losers
The top gainers on the Nifty included Dr. Reddys Laboratories, which surged by 1.49 per cent.20 Dec, 2024 04:12 PMAsian Paints Ltd Financials
Index Inclusions
Asian Paints Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 52.63% | 0.00 | |
| Foreign Institutions | 15.28% | 0.06 | |
| Mutual Funds | 4.86% | 27.87 | |
| Retail Investors | 18.88% | ||
| Others | 8.35% |
Asian Paints Ltd Key Indicators
Asian Paints Ltd Valuation
Asian Paints Ltd in the last 5 years
Lowest (47.59x)
May 9, 2024
Industry (43.20x)
December 19, 2024
Today (48.09x)
December 19, 2024
Highest (115.23x)
December 30, 2020
Asian Paints Ltd Earnings and Dividends
Asian Paints Ltd Earnings Results
Asian Paints Ltd’s net profit fell -42.37% since last year same period to ₹694.64Cr in the Q2 2024-2025. On a quarterly growth basis, Asian Paints Ltd has generated -40.63% fall in its net profits since last 3-months.
Read More about Earnings ResultsAsian Paints Ltd Dividends November,2024
In the quarter ending September 2024, Asian Paints Ltd has declared dividend of ₹4.25 - translating a dividend yield of 1.42%.
Read More about Dividends
Asian Paints Ltd Technicals Summary
Bearish
Neutral
Bullish
Asian Paints Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Asian Paints Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Asian Paints Ltd shares.
Asian Paints Ltd (ASIANPAINT) share price today is ₹2282.35
Asian Paints Ltd is listed on NSE
Asian Paints Ltd is listed on BSE
- Today’s highest price of Asian Paints Ltd is ₹2318.
- Today’s lowest price of Asian Paints Ltd is ₹2276.
PE Ratio of Asian Paints Ltd is 48.09
PE ratio = Asian Paints Ltd Market price per share / Asian Paints Ltd Earnings per share
Today’s traded volume of Asian Paints Ltd(ASIANPAINT) is 17.20L.
Today’s market capitalisation of Asian Paints Ltd(ASIANPAINT) is ₹224975.05Cr.
| Asian Paints Ltd(ASIANPAINT | Price |
|---|---|
52 Week High | ₹3422.95 |
52 Week Low | ₹2276 |
Asian Paints Ltd(ASIANPAINT) share price is ₹2282.35. It is down -33.32% from its 52 Week High price of ₹3422.95
Asian Paints Ltd(ASIANPAINT) share price is ₹2282.35. It is up 0.28% from its 52 Week Low price of ₹2276
| Asian Paints Ltd(ASIANPAINT | Returns |
|---|---|
1 Day Returns | -9.5% |
1 Month Returns | -5.61% |
3 Month Returns | -30.07% |
1 Year Returns | -30.61% |